SCOR Global Life, SCOR’s Life reinsurance branch, has signed a partnership agreement with the Pierre and Marie Curie University in France, in order to support research into the auto immune deficiency virus (HIV) led by the Pierre and Marie Curie University team at the Pitié-Salpêtrière hospital. The team is headed by Professor Brigitte Autran. Professor Autran and her team are recognised around the world for their work on the immunity controlling the HIV infection and the development of viral eradication strategies.

 

This partnership was formally sealed yersterday in the presence of Professor Autran, head of the “Antiviral and vaccinal immunity and immunogenetics” team at the joint UPMC/INSERM “Immunity and infection” laboratory, of Jean-Charles Pomerol, President of the Pierre and Marie Curie University, of Nicolas Crespelle, President of the Pierre and Marie Curie University Partnership Foundation, of Denis Kessler, Chairman and CEO of SCOR, and of Gilles Meyer, CEO of SCOR Global Life.

 

SCOR Global Life places particular importance on research and innovation, notably through its four international research and development centres dedicated to the enhancement of expertise in the field of Life and Health risks. These risk centres are: CIRDAD (Long-Term Care Insurance), CERDALM (Longevity and Mortality Insurance), CERDI (Disability and Critical Illness Insurance), and CREDISS (Medical Selection and Claims). SCOR Global Life’s research and development centres conduct a number of research projects in partnership with universities and foundations, notably on cardiovascular risks with the ASSMANN Foundation and on Alzheimer’s disease with the IFRAD Foundation.